SEC Form 4 · accession 0001209191-16-095292
INFINERA Corp · INFN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David F Welch
Officer — President · Director
Period of report
Feb 1, 2016
Accepted (ET)
Feb 3, 2016 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001138639
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 14,132 | D | ||
| Common StockF1 | holding | — | — | — | 273,709 | I | See Footnote | |
| Common StockF2 | holding | — | — | — | 140,000 | I | See Footnote | |
| Common StockF3 | holding | — | — | — | 319,493 | I | See Footnote | |
| Common StockF4 | holding | — | — | — | 553,750 | I | See Footnote | |
| Common StockF5 | holding | — | — | — | 2,500 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF7,F13 | — | Feb 1, 2016 | A | 37,500 | A | — | — | Common Stock | 37,500 | 37,500 | D |
| Restricted Stock UnitsF7,F14 | — | Feb 1, 2016 | A | 20,923 | A | — | — | Common Stock | 20,923 | 20,923 | D |
| Restricted Stock UnitsF7,F15 | — | Feb 1, 2016 | A | 9,015 | A | — | — | Common Stock | 9,015 | 9,015 | D |
| Employee Stock Option (Right to Buy)F6 | $2.00 | holding | — | — | — | — | Aug 8, 2016 | Common Stock | 50,000 | 50,000 | D |
| Employee Stock Option (Right to Buy)F6 | $2.00 | holding | — | — | — | — | Aug 8, 2016 | Common Stock | 137,500 | 137,500 | D |
| Employee Stock Option (Right to Buy)F6 | $8.19 | holding | — | — | — | — | Nov 23, 2016 | Common Stock | 75,000 | 75,000 | D |
| Employee Stock Option (Right to Buy)F6 | $7.61 | holding | — | — | — | — | Jun 6, 2017 | Common Stock | 29,214 | 29,214 | D |
| Employee Stock Option (Right to Buy)F6 | $7.61 | holding | — | — | — | — | Jun 6, 2017 | Common Stock | 101,342 | 101,342 | D |
| Employee Stock Option (Right to Buy)F6 | $7.61 | holding | — | — | — | — | Feb 28, 2018 | Common Stock | 2,817 | 2,817 | D |
| Employee Stock Option (Right to Buy)F6 | $7.61 | holding | — | — | — | — | Feb 28, 2018 | Common Stock | 81,683 | 81,683 | D |
| Employee Stock Option (Right to Buy)F6 | $7.11 | holding | — | — | — | — | Feb 10, 2019 | Common Stock | 100,000 | 100,000 | D |
| Employee Stock Option (Right to Buy)F6 | $7.45 | holding | — | — | — | — | Aug 10, 2019 | Common Stock | 150,000 | 150,000 | D |
| Employee Stock Option (Right to Buy)F6 | $8.58 | holding | — | — | — | — | Feb 10, 2021 | Common Stock | 20,250 | 20,250 | D |
| Employee Stock Option (Right to Buy)F6 | $8.58 | holding | — | — | — | — | Feb 10, 2021 | Common Stock | 60,750 | 60,750 | D |
| Employee Stock Option (Right to Buy)F6 | $8.58 | holding | — | — | — | — | Feb 10, 2021 | Common Stock | 39,465 | 39,465 | D |
| Employee Stock Option (Right to Buy)F6 | $8.58 | holding | — | — | — | — | Feb 10, 2021 | Common Stock | 41,535 | 41,535 | D |
| Restricted Stock UnitsF7,F8 | — | holding | — | — | — | — | — | Common Stock | 20,000 | 20,000 | D |
| Restricted Stock UnitsF7,F9 | — | holding | — | — | — | — | — | Common Stock | 24,000 | 24,000 | D |
| Restricted Stock UnitsF7,F10 | — | holding | — | — | — | — | — | Common Stock | 41,846 | 41,846 | D |
| Restricted Stock UnitsF7,F11 | — | holding | — | — | — | — | — | Common Stock | 28,770 | 28,770 | D |
| Restricted Stock UnitsF7,F12 | — | holding | — | — | — | — | — | Common Stock | 28,770 | 28,770 | D |
Explanation of responses
- F1These shares are held directly by The Welch Family Trust, for which Dr. Welch is a trustee.
- F10These RSUs vest in three annual installments beginning on May 5, 2015.
- F11These RSUs vest in three annual installments beginning on May 5, 2016.
- F12These RSUs vest as to 50% of the shares on May 5, 2017 and 50% of the shares on May 5, 2018.
- F13On January 30, 2013, Dr. Welch was granted a performance-based RSU award at target for 75,000 shares of common stock, subject to the achievement of certain performance criteria. One-third of the shares are eligible to vest in each performance period up to a maximum of 150% of target. The performance criteria related to these shares were met at 150% of target for the third performance period, as determined by the administrator per the terms of the original grant, and the common stock issuable with respect to these 37,500 performance-based RSUs will vest on February 5, 2016, subject to Dr. Welch's continuous status as a service provider through such date.
- F14On February 25, 2014, Dr. Welch was granted a performance-based RSU award at target for 41,847 shares of common stock, subject to the achievement of certain performance criteria. One-third of the shares are eligible to vest in each performance period up to a maximum of 150% of target. The performance criteria related to these shares were met at 150% of target for the second performance period, as determined by the administrator per the terms of the original grant, and the common stock issuable with respect to these 20,923 performance-based RSUs will vest on February 5, 2016, subject to Dr. Welch's continuous status as a service provider through such date.
- F15On February 24, 2015, Dr. Welch was granted a performance-based RSU award at target for 18,030 shares of common stock, subject to the achievement of certain performance criteria. One-third of the shares are eligible to vest in each performance period up to a maximum of 150% of target. The performance criteria related to these shares were met at 150% of target for the first performance period, as determined by the administrator per the terms of the original grant, and the common stock issuable with respect to these 9,015 performance-based RSUs will vest on February 5, 2016, subject to Dr. Welch's continuous status as a service provider through such date.
- F2These shares are held directly by The Welch Group, for which Dr. Welch is the general partner.
- F3These shares are held directly by LRFA, LLC, for which Dr. Welch is the sole managing member.
- F4These shares are held directly by SEI Private Trust Company, Trustee of The Welch Family Heritage Trust I u/I dated 9/24/01.
- F5These shares are held directly by Dr. Welch as a trustee for his children. Dr. Welch disclaims beneficial ownership of the shares held in trust for his children, and this report shall not be deemed an admission that Dr. Welch is the beneficial owner of the shares held in trust for his children for purposes of Section 16 or for any other purpose.
- F6This option is fully-vested.
- F7Each restricted stock unit ("RSU") represents a contingent right to receive one share of Infinera Corporation common stock.
- F8These RSUs vest in three annual installments beginning on February 5, 2014.
- F9These RSUs vest in four annual installments beginning on August 5, 2014.